Acute Coronary Syndrome Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theAcute Coronary Syndrome Market?
The growth of the acute coronary syndrome market is projected to be fueled by the rising occurrence of chronic illnesses like ischemic heart disease, coronary artery disease, and vascular diseases. Chronic diseases such as ischemic heart disease occur due to the gradual narrowing or blockage of the coronary arteries. The goal of acute coronary syndrome (ACS) treatment is to quickly alleviate symptoms, limit heart damage, and prevent additional complications in patients with various acute coronary syndromes, including ischemic heart disease and vascular diseases. For example, a study released in August 2022 in the Journal of the American College of Cardiology, an American institution, predicted that all four cardiovascular risk factors would rise among the general American population between 2025 and 2060, with dyslipidemia increasing by 27.6% and hypertension by 25.1%. The largest projected rate increases were found to be heart failure (33.4%) and ischemic heart disease (30.7%), trailed by heart attack (16.9%) and stroke (33.8%). This escalating presence of chronic illnesses such as coronary artery disease, ischemic heart disease, and vascular diseases propels the acute coronary syndrome market.
Acute Coronary Syndrome Market Driver: Healthcare Expenditure Increase Bolsters Advances in Coronary Syndrome Care
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12985&type=smp
#What is the Anticipated CAGR of theAcute Coronary Syndrome Market, and What Factors Will Drive It?
In recent times, the market for acute coronary syndrome has witnessed a significant rise. The market is anticipated to increase from a value of $9.86 billion in 2024 to $10.5 billion by 2025, growing at a compound annual growth rate (CAGR) of 6.5%. The past growth can be credited to factors such as public health drives, the uptake of telemedicine and remote monitoring services, better emergency medical support, and heightened demand for patient education.
The market for acute coronary syndrome is predicted to show robust expansion in the coming years, with an expected rise to $13.3 billion by 2029, reflecting a compound annual growth rate (CAGR) of 6.1%. This growth during the forecast period can be associated with the need for specialized medication, rise in interventional cardiology, enhanced awareness, and the increase in the global elderly population. Major forecasts for the period include advances in diagnostic tools, incorporation of health information technology, quick response systems, and technological progress.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12985
What Are the Current Market Growth and Trends in theAcute Coronary Syndrome Market That Industry Players Should Watch?
Leading corporations in the acute coronary syndrome market are focusing on the development of novel medicines to treat acute coronary syndrome and maintain their market stance. Enhancements in drug creation could increase the effectiveness of ACS treatment, thereby saving time and resources for every patient. For example, in June 2023, AGEPHA Pharma USA LLC, an American pharmaceutical firm, introduced Lodoco, granted approval by the Food and Drug Administration (FDA), a US governing body. This marks the first anti-inflammatory atheroprotective cardiovascular therapy that lowers the risk of heart stroke, coronary revascularization, myocardial infarction (MI), and cardiovascular death among adult patients with heart ailments, including acute coronary syndrome.
What Are the Major Market Players Making an Impact on theAcute Coronary Syndrome Market Growth?
Major companies operating in the acute coronary syndrome market are Pfizer Inc., Johnson and Johnson Limited, Siemens AG, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Stryker Corporation, GE Healthcare Inc., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited, Terumo Corp., BioMérieux SA, Beckman Coulter Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Biotronik Inc., Randox Laboratories Limited, Nihon Kohden Corporation, Trinity Biotech plc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/acute-coronary-syndrome-global-market-report
How Are the Key Segments of the Acute Coronary Syndrome Market Driving Opportunities and Innovations?
The acute coronary syndrome market covered in this report is segmented –
1) By Type: Non-St-Elevation Myocardial Infarction, St-Elevation Myocardial Infarction, Unstable Angina
2) By Treatment: Medications, Statins, Beta blockers, ACE inhibitors, Anticoagulants, Other Treatment
3) By Diagnosis: Stress Test, Blood Tests, Imaging, Other Diagnosis
4) By Route Of Administration: Oral, Parenteral
5) By End-User: Hospitals, Specialty clinics, Other End User
Subsegments:
1) By Non-ST-Elevation Myocardial Infarction: Medical Management, Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Grafting (CABG)
2) By ST-Elevation Myocardial Infarction: Medical Management, Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Grafting (CABG)
3) By Unstable Angina: Medical Management, Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Grafting (CABG)
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12985&type=smp
What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theAcute Coronary Syndrome Market?# Market Expansion?
North America was the largest region in the acute coronary syndrome market in 2024. The regions covered in acute coronary syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Reports Similar to the Global Acute Coronary Syndrome Market 2025, By The Business Research Company:
Cardiac Marker Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report
Cardiac Assist Devices And Equipment Global Market Report 2024
Cardiac Pacemakers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
